{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:56:10Z","timestamp":1782741370591,"version":"3.54.5"},"reference-count":152,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":173,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["108876\/B\/15\/Z."],"award-info":[{"award-number":["108876\/B\/15\/Z."]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.csbj.2021.06.034","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T19:33:17Z","timestamp":1624563197000},"page":"3708-3719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Structure-based\n                    <i>in silico<\/i>\n                    approaches for drug discovery against\n                    <i>Mycobacterium tuberculosis<\/i>"],"prefix":"10.34133","volume":"19","author":[{"given":"Alexander D.H.","family":"Kingdon","sequence":"first","affiliation":[{"name":"Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke J.","family":"Alderwick","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"WHO. Global Tuberculosis Report 2020; 2020."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the goals of prophylaxis","volume":"7","author":"Barry C.E.","year":"2009","unstructured":"Barry C.E., Boshoff H., Dartois V., Dick T., Ehrt S., Flynn J. et al: The spectrum of latent tuberculosis: rethinking the goals of prophylaxis. Nat Rev Microbiol 2009; 7: 845.","journal-title":"Nat Rev Microbiol"},{"key":"e_1_3_2_4_2","volume":"2","author":"Pai M.","year":"2016","unstructured":"Pai M., Behr M.A., Dowdy D., Dheda K., Divangahi M., Boehme C.C. et al: Tuberculosis Nat Rev Dis Prim 2016; 2.","journal-title":"Tuberculosis Nat Rev Dis Prim"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Maitra A Munshi T Healy J Martin LT Vollmer W Keep NH et al. Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles\u2019 heel for the TB-causing pathogen. FEMS Microbiol Rev 2019;43:548\u201375. https:\/\/doi.org\/10.1093\/femsre\/fuz016.","DOI":"10.1093\/femsre\/fuz016"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0273-7"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00010-14"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2174\/156802611795429158","article-title":"from Seven Decades of Antituberculosis Drug Discovery","volume":"11","author":"Barry E.","year":"2011","unstructured":"Barry E. and Lessons C.: from Seven Decades of Antituberculosis Drug Discovery. Curr Top Med Chem 2011; 11: 1216.","journal-title":"Curr Top Med Chem"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.45.120403.100120"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1093\/clinids\/5.Supplement_3.S402","article-title":"History of the Development of Rifampin","volume":"5","author":"Sensi P.","year":"1983","unstructured":"Sensi P.: History of the Development of Rifampin. Rev Infect Dis 1983; 5: S402.","journal-title":"Rev Infect Dis"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4001"},{"key":"e_1_3_2_12_2","unstructured":"WHO. Global Tuberculosis Report 2019. Geneva; 2019."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/35016103"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030466"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1021\/ci900419k","article-title":"Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation","volume":"50","author":"Geppert H.","year":"2010","unstructured":"Geppert H., Vogt M. and Bajorath J.: Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation. J Chem Inf Model 2010; 50: 205.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1549"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2174\/1568026617666170130110827","article-title":"A practical guide to molecular docking and homology modelling for medicinal chemists","volume":"17","author":"Lohning A.E.","year":"2017","unstructured":"Lohning A.E., Levonis S.M., Williams-Noonan B. and Schweiker S.S.: A practical guide to molecular docking and homology modelling for medicinal chemists. Curr Top Med Chem 2017; 17: 2023.","journal-title":"Curr Top Med Chem"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12275-020-9563-z","article-title":"User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation","volume":"58","author":"Shaker B.","year":"2020","unstructured":"Shaker B., Yu M.-S., Lee J., Lee Y., Jung C. and Na D.: User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation. J Microbiol 2020; 58: 235.","journal-title":"J Microbiol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5b00684"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02133-16"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/mmi.12546"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1923-7"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.235"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-9792(03)00051-9"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Bienert S Waterhouse A de Beer TAP Tauriello G Studer G Bordoli L et al. The SWISS-MODEL Repository\u2013new features and functionality. Nucleic Acids Res 2017;45:313\u20139. https:\/\/doi.org\/10.1093\/nar\/gkw1132.","DOI":"10.1093\/nar\/gkw1132"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"e1008667","DOI":"10.1371\/journal.pcbi.1008667","article-title":"ProMod3\u2014A versatile homology modelling toolbox","volume":"17","author":"Studer G.","year":"2021","unstructured":"Studer G., Tauriello G., Bienert S., Biasini M., Johner N., Schwede T. et al: ProMod3\u2014A versatile homology modelling toolbox. PLoS Comput Biol 2021; 17: e1008667.","journal-title":"PLoS Comput Biol"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang Y.","year":"2008","unstructured":"Zhang Y.: I-TASSER server for protein 3D structure prediction. BMC Bioinf 2008; 9: 1.","journal-title":"BMC Bioinf"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.053"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5b00559"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","unstructured":"Mendez D Gaulton A Bento AP Chambers J De Veij M Paula Magari\u00f1os M et al. ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res 2019;47:D930\u201340. https:\/\/doi.org\/10.1093\/nar\/gky1075.","DOI":"10.1093\/nar\/gky1075"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-020-2117-z","article-title":"An open-source drug discovery platform enables ultra-large virtual screens","volume":"580","author":"Gorgulla C.","year":"2020","unstructured":"Gorgulla C., Boeszoermenyi A., Wang Z.-F., Fischer P.D., Coote P.W., Padmanabha Das K.M. et al: An open-source drug discovery platform enables ultra-large virtual screens. Nature 2020; 580: 663.","journal-title":"Nature"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.02.013"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1039\/D0MD00265H"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1039\/b917766c"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.01.021"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"e0213713","DOI":"10.1371\/journal.pone.0213713","article-title":"Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria","volume":"14","author":"Kanvatirth P.","year":"2019","unstructured":"Kanvatirth P., Jeeves R.E., Bacon J., Besra G.S., Alderwick L.J. and Shin S.J.: Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria. PLoS ONE 2019; 14: e0213713.","journal-title":"PLoS ONE"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4306"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0026-895X(24)23192-8","article-title":"Accommodating Protein Flexibility in Computational Drug Design","volume":"57","author":"Carlson H.A.","year":"2000","unstructured":"Carlson H.A. and McCammon J.A.: Accommodating Protein Flexibility in Computational Drug Design. Mol Pharmacol 2000; 57: 213.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s001090000084","article-title":"Recent developments in structure-based drug design","volume":"78","author":"Klebe G.","year":"2000","unstructured":"Klebe G.: Recent developments in structure-based drug design. J Med Mol 2000; 78: 269.","journal-title":"J Med Mol"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2009.02.010"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0897"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk M.L.","year":"2003","unstructured":"Verdonk M.L., Cole J.C., Hartshorn M.J., Murray C.W. and Taylor R.D.: Improved protein-ligand docking using GOLD. Proteins 2003; 52: 609.","journal-title":"Proteins"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0306430"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm030644s"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/acs.jcim.8b00216","article-title":"Development and Validation of Molecular Overlays Derived from 3D Hydrophobic Similarity with PharmScreen","volume":"58","author":"V\u00e1zquez J.","year":"2018","unstructured":"V\u00e1zquez J., Deplano A., Herrero A., Ginex T., Gibert E., Rabal O. et al: Development and Validation of Molecular Overlays Derived from 3D Hydrophobic Similarity with PharmScreen. J Chem Inf Model 2018; 58: 1596.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/prot.20149","article-title":"Comparative evaluation of eight docking tools for docking and virtual screening accuracy","volume":"57","author":"Kellenberger E.","year":"2004","unstructured":"Kellenberger E., Rodrigo J., Muller P. and Rognan D.: Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins Struct Funct Genet 2004; 57: 225.","journal-title":"Proteins Struct Funct Genet"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular Docking and Structure-Based Drug Design Strategies","volume":"20","author":"Ferreira L.G.","year":"2015","unstructured":"Ferreira L.G., Dos Santos R.N., Oliva G. and Andricopulo A.D.: Molecular Docking and Structure-Based Drug Design Strategies. Molecules 2015; 20: 13384.","journal-title":"Molecules"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules22112029","article-title":"Dynamic docking: A paradigm shift in computational drug discovery","volume":"22","author":"Gioia D.","year":"2017","unstructured":"Gioia D., Bertazzo M., Recanatini M., Masetti M. and Cavalli A.: Dynamic docking: A paradigm shift in computational drug discovery. Molecules 2017; 22: 1.","journal-title":"Molecules"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25112487","article-title":"A Deep-Learning Approach toward Rational Molecular Docking Protocol Selection","volume":"25","author":"Jim\u00e9nez-Luna J.","year":"2020","unstructured":"Jim\u00e9nez-Luna J., Cuzzolin A., Bolcato G., Sturlese M. and Moro S.: A Deep-Learning Approach toward Rational Molecular Docking Protocol Selection. Molecules 2020; 25: 1.","journal-title":"Molecules"},{"key":"e_1_3_2_51_2","first-page":"1354","article-title":"Mycobacterial drug discovery. RSC","volume":"11","author":"Abrahams K.A.","year":"2020","unstructured":"Abrahams K.A. and Besra G.S.: Mycobacterial drug discovery. RSC. Med Chem 2020; 11: 1354.","journal-title":"Med Chem"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/DDDT.S119930","article-title":"In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA)","volume":"11","author":"Billones J.B.","year":"2017","unstructured":"Billones J.B., Carrillo M.C.O., Organo V.G., Sy J.B.A., Macalino S.J.Y., Emnacen I.A. et al: In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA). Drug Des Devel Ther 2017; 11: 563.","journal-title":"Drug Des Devel Ther"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1080\/07391102.2019.1657499","article-title":"Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium tuberculosis","volume":"38","author":"Kumar N.","year":"2020","unstructured":"Kumar N., Srivastava R., Prakash A. and Lynn A.M.: Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium tuberculosis. J Biomol Struct Dyn 2020; 38: 3396.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1039\/C7OB00910K"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a021147","article-title":"Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm","volume":"5","author":"Chakraborty S.","year":"2015","unstructured":"Chakraborty S. and Rhee K.Y.: Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm. Cold Spring Harb Perspect Med 2015; 5: 1.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.8b00712"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/jm100488w","article-title":"Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors","volume":"53","author":"Ferreira R.S.","year":"2010","unstructured":"Ferreira R.S., Simeonov A., Jadhav A., Eidam O., Mott B.T., Keiser M.J. et al: Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors. J Med Chem 2010; 53: 4891.","journal-title":"J Med Chem"},{"key":"e_1_3_2_58_2","first-page":"1","article-title":"Machine-learning scoring functions for structure-based drug lead optimization","volume":"10","author":"Li H.","year":"2020","unstructured":"Li H., Sze K., Lu G. and Ballester P.J.: Machine-learning scoring functions for structure-based drug lead optimization. WIREs Comput Mol Sci 2020; 10: 1.","journal-title":"WIREs Comput Mol Sci"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wcms.1429","article-title":"From machine learning to deep learning: Advances in scoring functions for protein\u2013ligand docking","volume":"10","author":"Shen C.","year":"2020","unstructured":"Shen C., Ding J., Wang Z., Cao D., Ding X. and Hou T.: From machine learning to deep learning: Advances in scoring functions for protein\u2013ligand docking. Wiley Interdiscip Rev Comput Mol Sci 2020; 10: 1.","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ddtec.2020.09.001","article-title":"Selecting machine-learning scoring functions for structure-based virtual screening","volume":"32","author":"Ballester P.J.","year":"2019","unstructured":"Ballester P.J.: Selecting machine-learning scoring functions for structure-based virtual screening. Drug Discov Today Technol 2019; 32: 81.","journal-title":"Drug Discov Today Technol"},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/biom8010012","article-title":"The Impact of Protein Structure and Sequence Similarity on the Accuracy of Machine-Learning Scoring Functions for Binding Affinity Prediction","volume":"8","author":"Li H.","year":"2018","unstructured":"Li H., Peng J., Leung Y., Leung K.-S., Wong M.-H., Lu G. et al: The Impact of Protein Structure and Sequence Similarity on the Accuracy of Machine-Learning Scoring Functions for Binding Affinity Prediction. Biomolecules 2018; 8: 12.","journal-title":"Biomolecules"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-015-0078-2","article-title":"Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field","volume":"7","author":"W\u00f3jcikowski M.","year":"2015","unstructured":"W\u00f3jcikowski M., Zielenkiewicz P. and Siedlecki P.: Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field. J Cheminform 2015; 7: 1.","journal-title":"J Cheminform"},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1021\/ci2003889","article-title":"NNScore 2.0: A Neural-Network Receptor-Ligand Scoring Function","volume":"51","author":"Durrant J.D.","year":"2011","unstructured":"Durrant J.D. and McCammon J.A.: NNScore 2.0: A Neural-Network Receptor-Ligand Scoring Function. J Chem Inf Model 2011; 51: 2897.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/acs.jcim.8b00673","article-title":"Improved Method of Structure-Based Virtual Screening via Interaction-Energy-Based Learning","volume":"59","author":"Yasuo N.","year":"2019","unstructured":"Yasuo N. and Sekijima M.: Improved Method of Structure-Based Virtual Screening via Interaction-Energy-Based Learning. J Chem Inf Model 2019; 59: 1050.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep46710","article-title":"Performance of machine-learning scoring functions in structure-based virtual screening","volume":"7","author":"W\u00f3jcikowski M.","year":"2017","unstructured":"W\u00f3jcikowski M., Ballester P.J. and Siedlecki P.: Performance of machine-learning scoring functions in structure-based virtual screening. Sci Rep 2017; 7: 1.","journal-title":"Sci Rep"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm300687e"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1021\/ci100244v","article-title":"NNScore: A Neural-Network-Based Scoring Function for the Characterization of Protein-Ligand Complexes","volume":"50","author":"Durrant J.D.","year":"2010","unstructured":"Durrant J.D. and McCammon J.A.: NNScore: A Neural-Network-Based Scoring Function for the Characterization of Protein-Ligand Complexes. J Chem Inf Model 2010; 50: 1865.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"8764","DOI":"10.1039\/C9SC02520K","article-title":"Discovery of small-molecular inhibitors targeting the ribosomal peptidyl transferase center (PTC) of M. tuberculosis","volume":"10","author":"Tam B.","year":"2019","unstructured":"Tam B., Sherf D., Cohen S., Eisdorfer S.A., Perez M., Soffer A. et al: Discovery of small-molecular inhibitors targeting the ribosomal peptidyl transferase center (PTC) of M. tuberculosis. Chem Sci 2019; 10: 8764.","journal-title":"Chem Sci"},{"key":"e_1_3_2_69_2","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1080\/07391102.2019.1637280","article-title":"Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis","volume":"38","author":"Rani J.","year":"2020","unstructured":"Rani J., Silla Y., Borah K., Ramachandran S. and Bajpai U.: Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis. J Biomol Struct Dyn 2020; 38: 2521.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.9b00295"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci500672v"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23030524"},{"key":"e_1_3_2_73_2","first-page":"1","article-title":"Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach","volume":"8","author":"Tuhin Ali M.","year":"2018","unstructured":"Tuhin Ali M., Blicharska N., Shilpi J.A. and Seidel V.: Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach. Sci Rep 2018; 8: 1.","journal-title":"Sci Rep"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.8b00963"},{"key":"e_1_3_2_75_2","article-title":"Ensemble-based high-throughput virtual screening of natural ligands using the Super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in Mycobacterium tuberculosis","volume":"1","author":"Ravichandran R.","year":"2020","unstructured":"Ravichandran R., Farrah Wahidah Ridzwan N. and Bin M.S.: Ensemble-based high-throughput virtual screening of natural ligands using the Super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in Mycobacterium tuberculosis. J Biomol Struct Dyn Dyn 2020; 1\u201310.","journal-title":"J Biomol Struct Dyn Dyn"},{"key":"e_1_3_2_76_2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/DDDT.S97043","article-title":"Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis l, d-transpeptidase 2","volume":"10","author":"Billones J.B.","year":"2016","unstructured":"Billones J.B., Carrillo M.C.O., Organo V.G., Macalino S.J.Y., Sy J.B.A., Clavio N.A.B. et al: Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis l, d-transpeptidase 2. Drug Des Devel Ther 2016; 10: 1147.","journal-title":"Drug Des Devel Ther"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028428"},{"key":"e_1_3_2_78_2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1080\/07391102.2018.1454852","article-title":"Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae","volume":"37","author":"Kaur G.","year":"2019","unstructured":"Kaur G., Pandey B., Kumar A., Garewal N., Grover A. and Kaur J.: Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae. J Biomol Struct Dyn 2019; 37: 1254.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_2_79_2","doi-asserted-by":"crossref","unstructured":"Sivaranjani P. Naik V.U. Madhulitha N.R. Kumar K.S. Chiranjeevi P. Alexander S.P. et al: Design of Novel Antimycobacterial Molecule Targeting Shikimate Pathway of Mycobacterium tuberculosis. Indian J Pharm Sci 2019; 81: 438. https:\/\/doi.org\/10.36468\/pharmaceutical-sciences.528.","DOI":"10.36468\/pharmaceutical-sciences.528"},{"key":"e_1_3_2_80_2","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1080\/07391102.2019.1695670","article-title":"Virtual screening to identify novel potential inhibitors for Glutamine synthetase of Mycobacterium tuberculosis","volume":"38","author":"Kumari M.","year":"2020","unstructured":"Kumari M. and Subbarao N.: Virtual screening to identify novel potential inhibitors for Glutamine synthetase of Mycobacterium tuberculosis. J Biomol Struct Dyn 2020; 38: 5062.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_2_81_2","doi-asserted-by":"crossref","first-page":"107770","DOI":"10.1016\/j.jmgm.2020.107770","article-title":"Virtual screening and free energy estimation for identifying Mycobacterium tuberculosis flavoenzyme DprE1 inhibitors","volume":"102","author":"Niranjan Kumar","year":"2021","unstructured":"Niranjan Kumar , Srivastava R., Prakash A. and Lynn A.M.: Virtual screening and free energy estimation for identifying Mycobacterium tuberculosis flavoenzyme DprE1 inhibitors. J Mol Graph Model 2021; 102: 107770.","journal-title":"J Mol Graph Model"},{"key":"e_1_3_2_82_2","doi-asserted-by":"crossref","first-page":"100210","DOI":"10.1016\/j.imu.2019.100210","article-title":"Molecular docking, molecular dynamics and MM\/PBSA studies of FDA approved drugs for protein kinase a of Mycobacterium tuberculosis; application insights of drug repurposing","volume":"16","author":"Sundar S.","year":"2019","unstructured":"Sundar S., Thangamani L., Manivel G., Kumar P. and Piramanayagam S.: Molecular docking, molecular dynamics and MM\/PBSA studies of FDA approved drugs for protein kinase a of Mycobacterium tuberculosis; application insights of drug repurposing. Informatics Med Unlocked 2019; 16: 100210.","journal-title":"Informatics Med Unlocked"},{"key":"e_1_3_2_83_2","doi-asserted-by":"crossref","first-page":"2000211","DOI":"10.1002\/minf.202000211","article-title":"Targeting Mycobacterium Tuberculosis Enoyl-acyl Carrier Protein Reductase using Computational Tools for Identification of Potential Inhibitor and their Biological Activity","volume":"40","author":"Kuldeep J.","year":"2021","unstructured":"Kuldeep J., Sharma S.K., Sharma T., Singh B.N. and Siddiqi M.I.: Targeting Mycobacterium Tuberculosis Enoyl-acyl Carrier Protein Reductase using Computational Tools for Identification of Potential Inhibitor and their Biological Activity. Mol Inform 2021; 40: 2000211.","journal-title":"Mol Inform"},{"key":"e_1_3_2_84_2","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1080\/07391102.2018.1526715","article-title":"Inhibitor binding studies of Mycobacterium tuberculosis MraY (Rv2156c): Insights from molecular modeling, docking, and simulation studies","volume":"37","author":"Mallavarapu B.D.","year":"2019","unstructured":"Mallavarapu B.D., Abdullah M., Saxena S. and Guruprasad L.: Inhibitor binding studies of Mycobacterium tuberculosis MraY (Rv2156c): Insights from molecular modeling, docking, and simulation studies. J Biomol Struct Dyn 2019; 37: 3751.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_2_85_2","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1021\/acs.jpclett.9b00741","article-title":"Relative Binding Energies Predict Crystallographic Binding Modes of Ethionamide Booster Lead Compounds","volume":"10","author":"Tatum N.J.","year":"2019","unstructured":"Tatum N.J., Duarte F., Kamerlin S.C.L. and Pohl E.: Relative Binding Energies Predict Crystallographic Binding Modes of Ethionamide Booster Lead Compounds. J Phys Chem Lett 2019; 10: 2244.","journal-title":"J Phys Chem Lett"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00083"},{"key":"e_1_3_2_87_2","doi-asserted-by":"crossref","first-page":"29935","DOI":"10.1021\/acsomega.0c04271","article-title":"Computational Approaches to Identify Molecules Binding to Mycobacterium tuberculosis KasA","volume":"5","author":"Puhl A.C.","year":"2020","unstructured":"Puhl A.C., Lane T.R., Vignaux P.A., Zorn K.M., Capodagli G.C., Neiditch M.B. et al: Computational Approaches to Identify Molecules Binding to Mycobacterium tuberculosis KasA. ACS Omega 2020; 5: 29935.","journal-title":"ACS Omega"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci400202t"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.06.033"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2012.0569"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-016-1734-4"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/267585a0"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20289"},{"key":"e_1_3_2_94_2","first-page":"37","article-title":"Molecular dynamics simulations: advances and applications","volume":"8","author":"Hospital A.","year":"2015","unstructured":"Hospital A., Go\u00f1i J.R., Orozco M. and Gelp\u00ed J.L.: Molecular dynamics simulations: advances and applications. Adv Appl Bioinforma Chem 2015; 8: 37.","journal-title":"Adv Appl Bioinforma Chem"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21367"},{"key":"e_1_3_2_96_2","doi-asserted-by":"crossref","first-page":"E4758","DOI":"10.1073\/pnas.1800690115","article-title":"Developing a molecular dynamics force field for both folded and disordered protein states","volume":"115","author":"Robustelli P.","year":"2018","unstructured":"Robustelli P., Piana S. and Shaw D.E.: Developing a molecular dynamics force field for both folded and disordered protein states. PNAS 2018; 115: E4758.","journal-title":"PNAS"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.08.011"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20290"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.540040211"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.5b00935"},{"key":"e_1_3_2_102_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"Visual Molecular Dynamics","volume":"14","author":"Humphrey W.","year":"1996","unstructured":"Humphrey W., Dalke A. and Schulten K.: Visual Molecular Dynamics. J Mol Graph 1996; 14: 33.","journal-title":"J Mol Graph"},{"key":"e_1_3_2_103_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10822-016-9977-1","article-title":"Lessons learned from comparing molecular dynamics engines on the SAMPL5 dataset","volume":"31","author":"Shirts M.R.","year":"2017","unstructured":"Shirts M.R., Klein C., Swails J.M., Yin J., Gilson M.K., Mobley D.L. et al: Lessons learned from comparing molecular dynamics engines on the SAMPL5 dataset. J Comput Aided Mol Des 2017; 31: 147.","journal-title":"J Comput Aided Mol Des"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004619"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2013.06.004"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2014.11.011"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2018.02.038"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011511107"},{"key":"e_1_3_2_109_2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1021\/acs.jcim.8b00730","article-title":"Holo-like and Druggable Protein Conformations from Enhanced Sampling of Binding Pocket Volume and Shape","volume":"59","author":"Basciu A.","year":"2019","unstructured":"Basciu A., Malloci G., Pietrucci F., Bonvin A.M.J.J. and Vargiu A.V.: Holo-like and Druggable Protein Conformations from Enhanced Sampling of Binding Pocket Volume and Shape. J Chem Inf Model 2019; 59: 1515.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_2_110_2","first-page":"1","article-title":"Implementation of Accelerated Molecular Dynamics in NAMD","volume":"4","author":"Wang Y.","year":"2012","unstructured":"Wang Y., Harrison C.B., Schulten K. and Mccammon J.A.: Implementation of Accelerated Molecular Dynamics in NAMD. Comput Sci Discov 2012; 4: 1.","journal-title":"Comput Sci Discov"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.1755656"},{"key":"e_1_3_2_112_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0009-2614(99)01123-9","article-title":"Replica exchange molecular dynamics method for protein folding simulation","volume":"314","author":"Sugita Y.","year":"1999","unstructured":"Sugita Y. and Okamoto Y.: Replica exchange molecular dynamics method for protein folding simulation. Chem Phys Lett 1999; 314: 141.","journal-title":"Chem Phys Lett"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2016.01.007"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physchem-042018-052331"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.4966192"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-020-00346-6"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2019.12.016"},{"key":"e_1_3_2_118_2","first-page":"1","article-title":"A survey of algorithms for transforming molecular dynamics data into metadata for in situ analytics based on machine learning methods","volume":"378","author":"Taufer M.","year":"2020","unstructured":"Taufer M., Estrada T. and Johnston T.: A survey of algorithms for transforming molecular dynamics data into metadata for in situ analytics based on machine learning methods. Philos Trans R Soc London A 2020; 378: 1.","journal-title":"Philos Trans R Soc London A"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.8b00908"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpc.2020.107624"},{"key":"e_1_3_2_121_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2019.00025","article-title":"Anncolvar: Approximation of complex collective variables by artificial neural networks for analysis and biasing of molecular simulations","volume":"6","author":"Trapl D.","year":"2019","unstructured":"Trapl D., Horvacanin I., Mareska V., Ozcelik F., Unal G. and Spiwok V.: Anncolvar: Approximation of complex collective variables by artificial neural networks for analysis and biasing of molecular simulations. Front Mol Biosci 2019; 6: 1.","journal-title":"Front Mol Biosci"},{"key":"e_1_3_2_122_2","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1021\/acsomega.9b01480","article-title":"Enhancing Biomolecular Sampling with Reinforcement Learning: A Tree Search Molecular Dynamics Simulation Method","volume":"4","author":"Shin K.","year":"2019","unstructured":"Shin K., Tran D.P., Takemura K., Kitao A., Terayama K. and Tsuda K.: Enhancing Biomolecular Sampling with Reinforcement Learning: A Tree Search Molecular Dynamics Simulation Method. ACS Omega 2019; 4: 13853.","journal-title":"ACS Omega"},{"key":"e_1_3_2_123_2","doi-asserted-by":"crossref","unstructured":"Terayama K Iwata H Araki M Okuno Y Tsuda K. Machine learning accelerates MD-based binding pose prediction between ligands and proteins. Bioinformatics 2018;34:770\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btx638.","DOI":"10.1093\/bioinformatics\/btx638"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2019.03.018"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1002\/bip.10218"},{"key":"e_1_3_2_126_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/prot.10028","article-title":"Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in autodock","volume":"46","author":"\u00d6sterberg F.","year":"2002","unstructured":"\u00d6sterberg F., Morris G.M., Sanner M.F., Olson A.J. and Goodsell D.S.: Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in autodock. Proteins Struct Funct Genet 2002; 46: 34.","journal-title":"Proteins Struct Funct Genet"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-007-9159-2"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/9.11.1063"},{"key":"e_1_3_2_129_2","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1021\/acs.jctc.7b00500","article-title":"POVME 3.0: Software for Mapping Binding Pocket Flexibility","volume":"13","author":"Wagner J.R.","year":"2017","unstructured":"Wagner J.R., S\u00f8rensen J., Hensley N., Wong C., Zhu C., Perison T. et al: POVME 3.0: Software for Mapping Binding Pocket Flexibility. J Chem Theory Comput 2017; 13: 4584.","journal-title":"J Chem Theory Comput"},{"key":"e_1_3_2_130_2","first-page":"1","article-title":"Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies","volume":"9","author":"Ortiz C.L.D.","year":"2019","unstructured":"Ortiz C.L.D., Completo G.C., Nacario R.C. and Nellas R.B.: Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies. Sci Rep 2019; 9: 1.","journal-title":"Sci Rep"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1021\/ct400341p"},{"key":"e_1_3_2_132_2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/cbdd.12900","article-title":"ENRI: A tool for selecting structure-based virtual screening target conformations","volume":"89","author":"Akbar R.","year":"2017","unstructured":"Akbar R., Jusoh S.A., Amaro R.E. and Helms V.: ENRI: A tool for selecting structure-based virtual screening target conformations. Chem Biol Drug Des 2017; 89: 762.","journal-title":"Chem Biol Drug Des"},{"key":"e_1_3_2_133_2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden S.","year":"2015","unstructured":"Genheden S. and Ryde U.: The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 2015; 10: 449.","journal-title":"Expert Opin Drug Discov"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.06.002"},{"key":"e_1_3_2_135_2","doi-asserted-by":"crossref","unstructured":"Shirts MR Mobley DL Chodera JD. Alchemical Free Energy Calculations: Ready for Prime Time? Annu. Rep. Comput. Chem. vol. 3 Elsevier B.V.; 2007 p. 41\u201359. https:\/\/doi.org\/10.1016\/S1574-1400(07)03004-6.","DOI":"10.1016\/S1574-1400(07)03004-6"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1021\/jp807701h"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.24467"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.9b00055"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1021\/ar000033j"},{"key":"e_1_3_2_140_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-3495(04)74084-9","article-title":"Revisiting Free Energy Calculations: A Theoretical Connection to MM\/PBSA and Direct Calculation of the Association Free Energy","volume":"86","author":"Swanson J.M.J.","year":"2004","unstructured":"Swanson J.M.J., Henchman R.H. and McCammon J.A.: Revisiting Free Energy Calculations: A Theoretical Connection to MM\/PBSA and Direct Calculation of the Association Free Energy. Biophys J 2004; 86: 67.","journal-title":"Biophys J"},{"key":"e_1_3_2_141_2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/prot.24029","article-title":"Comparison of end-point continuum-solvation methods for the calculation of protein-ligand binding free energies","volume":"80","author":"Genheden S.","year":"2012","unstructured":"Genheden S. and Ryde U.: Comparison of end-point continuum-solvation methods for the calculation of protein-ligand binding free energies. Proteins Struct Funct Bioinforma 2012; 80: 1326.","journal-title":"Proteins Struct Funct Bioinforma"},{"key":"e_1_3_2_142_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1039\/C3MB70449A","article-title":"Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis","volume":"10","author":"Ntie-Kang F.","year":"2014","unstructured":"Ntie-Kang F., Kannan S., Wichapong K., Owono Owono L.C., Sippl W. and Megnassan E.: Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis. Mol BioSyst 2014; 10: 223.","journal-title":"Mol BioSyst"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1002\/prot.23106"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1021\/ct200230v"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci400312v"},{"key":"e_1_3_2_146_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10822-020-00363-5","article-title":"SAMPL7 Host-Guest Challenge Overview: assessing the reliability of polarizable and non-polarizable methods for binding free energy calculations","volume":"35","author":"Amezcua M.","year":"2021","unstructured":"Amezcua M., El Khoury L. and Mobley D.L.: SAMPL7 Host-Guest Challenge Overview: assessing the reliability of polarizable and non-polarizable methods for binding free energy calculations. J Comput Aided Mol Des 2021; 35: 1.","journal-title":"J Comput Aided Mol Des"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00718"},{"key":"e_1_3_2_148_2","doi-asserted-by":"crossref","first-page":"28529","DOI":"10.1021\/acsomega.0c03177","article-title":"Analysis of Approaches to Anti-tuberculosis Compounds","volume":"5","author":"Motamen S.","year":"2020","unstructured":"Motamen S. and Quinn R.J.: Analysis of Approaches to Anti-tuberculosis Compounds. ACS Omega 2020; 5: 28529.","journal-title":"ACS Omega"},{"key":"e_1_3_2_149_2","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1039\/C6MB00457A","article-title":"Modeling the permeability of drug-like molecules through the cell wall of Mycobacterium tuberculosis: an analogue based approach","volume":"12","author":"Janardhan S.","year":"2016","unstructured":"Janardhan S., Ram Vivek M. and Narahari Sastry G.: Modeling the permeability of drug-like molecules through the cell wall of Mycobacterium tuberculosis: an analogue based approach. Mol BioSyst 2016; 12: 3377.","journal-title":"Mol BioSyst"},{"key":"e_1_3_2_150_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bioinformatics\/bts641","article-title":"Structural bioinformatics MycPermCheck: the Mycobacterium tuberculosis permeability prediction tool for small molecules","volume":"29","author":"Merget B.","year":"2013","unstructured":"Merget B., Zilian D., M\u00fcller T. and Sotriffer C.A.: Structural bioinformatics MycPermCheck: the Mycobacterium tuberculosis permeability prediction tool for small molecules. Bioinformatics 2013; 29: 62.","journal-title":"Bioinformatics"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci500077v"},{"key":"e_1_3_2_152_2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1021\/bm0345155","article-title":"Molecular Modeling and Simulation of Mycobacterium tuberculosis Cell Wall Permeability","volume":"5","author":"Hong X.","year":"2004","unstructured":"Hong X. and Hopfinger A.J.: Molecular Modeling and Simulation of Mycobacterium tuberculosis Cell Wall Permeability. Biomacromolecules 2004; 5: 1066.","journal-title":"Biomacromolecules"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.12.009"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021002725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021002725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2021.06.034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:38:21Z","timestamp":1779021501000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2021.06.034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":152,"alternative-id":["10.1016\/j.csbj.2021.06.034"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2021.06.034","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2021.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}